To assess the role of Opa1 in post-infarction cardiac damage, an in vitro model was established by introducing Opa1-expressing adenoviral vectors (Ad-Opa1) or a siRNA targeting Opa1 (si-Opa1) into primary cardiomyocytes isolated from neonatal mice. The gene discussed is OPA1; the disease is infarction.